skip to Main Content
May 21, 2019 1:00 - 1:45 PM ET

A Conversation on Oncology: Download the Slides and Listen to the Recording

  • This page as PDF


Ahead of the American Society of Clinical Oncology's annual meeting, Avalere experts discussed the latest trends in policy, reimbursement, and market access reshaping oncology care.

The oncology landscape continues to see significant changes as public focus on costs is amplified by drug pricing reforms, providers take on more financial risk, and clinical advancements outpace existing regulatory and reimbursement mechanisms. Provider participation in initiatives such as the Oncology Care Model (OCM) has spurred transformation in oncology care necessitating life science companies to seek new ways to demonstrate value. It is critical to understand how implementation of new reforms and initiatives could impact providers and patients from an access, quality, and affordability perspective.

On May 21, Avalere experts unpacked the complex dynamics stakeholders must consider, spanning policy, market access and reimbursement, and regulatory implications. Meet with us at the annual meeting of the American Society of Clinical Oncology to continue the conversation.

Key Topics

  • Impact of drug pricing policy proposals
  • Evolution of the OCM
  • Reimbursement approaches to novel therapies (e.g., CAR-T)
  • Evidence Generation and FDAMA 114 Opportunities
  • Differential pricing for combination and multi-indication regimens


Dana Macher , Managing Director, Market Access & Reimbursement

Dana Macher specializes in market access and commercialization.

Lance Grady , Practice Director, Market Access & Reimbursement

As the leader of the Market Access Practice, Lance Grady devises commercialization strategies focused on value, access, and reimbursement.

Richard Kane , Associate Principal, Policy

Richard Kane provides data-driven analysis and economic insights for clients across multiple sectors.

Milena Sullivan , Principal, Policy

Milena Sullivan advises life sciences clients on the impact of the evolving healthcare policy landscape on their commercial, access, and advocacy priorities.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Value-Based Care
Please enter your email address to be notified when new Value-Based Care insights are published.

Back To Top